ADIPOQ and Insulin resistance: Disruption of adiponectin leads to high-fat diet–induced insulin resistance and levels are low in humans with obesity and insulin resistance while adiponectin levels are increased by insulin-sensitizing peroxisome proliferator-activated receptors (PPAR)γ agonists.